However, one ongoing problem in disease-related MFN2 research is the lack of a knock-in mouse that accurately models the genetics AND the severe, early-onset peripheral neuropathy phenotypes commonly seen in patients with CMT2A, despite a great deal of effort to produce such mouse models [27,37,38,39]. This evidence concerns the gene MFN2 and peripheral neuropathy.